Lee Dale, Albenberg Lindsey, Compher Charlene, Baldassano Robert, Piccoli David, Lewis James D, Wu Gary D
Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Gastroenterology. 2015 May;148(6):1087-106. doi: 10.1053/j.gastro.2015.01.007. Epub 2015 Jan 15.
Some of the most common symptoms of the inflammatory bowel diseases (IBD, which include ulcerative colitis and Crohn's disease) are abdominal pain, diarrhea, and weight loss. It is therefore not surprising that clinicians and patients have wondered whether dietary patterns influence the onset or course of IBD. The question of what to eat is among the most commonly asked by patients, and among the most difficult to answer for clinicians. There are substantial variations in dietary behaviors of patients and recommendations for them, although clinicians do not routinely endorse specific diets for patients with IBD. Dietary clinical trials have been limited by their inability to include a placebo control, contamination of study groups, and inclusion of patients receiving medical therapies. Additional challenges include accuracy of information on dietary intake, complex interactions between foods consumed, and differences in food metabolism among individuals. We review the roles of diet in the etiology and management of IBD based on plausible mechanisms and clinical evidence. Researchers have learned much about the effects of diet on the mucosal immune system, epithelial function, and the intestinal microbiome; these findings could have significant practical implications. Controlled studies of patients receiving enteral nutrition and observations made from patients on exclusion diets have shown that components of whole foods can have deleterious effects for patients with IBD. Additionally, studies in animal models suggested that certain nutrients can reduce intestinal inflammation. In the future, engineered diets that restrict deleterious components but supplement beneficial nutrients could be used to modify the luminal intestinal environment of patients with IBD; these might be used alone or in combination with immunosuppressive agents, or as salvage therapy for patients who do not respond or lose responsiveness to medical therapies. Stricter diets might be required to induce remission, and more sustainable exclusion diets could be used to maintain long-term remission.
炎症性肠病(IBD,包括溃疡性结肠炎和克罗恩病)最常见的一些症状是腹痛、腹泻和体重减轻。因此,临床医生和患者怀疑饮食模式是否会影响IBD的发病或病程也就不足为奇了。吃什么的问题是患者最常问的问题之一,也是临床医生最难回答的问题之一。患者的饮食行为和针对他们的建议存在很大差异,尽管临床医生通常不会为IBD患者推荐特定的饮食。饮食临床试验受到多种限制,包括无法纳入安慰剂对照、研究组受到污染以及纳入正在接受药物治疗的患者。其他挑战包括饮食摄入量信息的准确性、所摄入食物之间复杂的相互作用以及个体之间食物代谢的差异。我们基于合理的机制和临床证据,综述饮食在IBD病因和管理中的作用。研究人员已经对饮食对黏膜免疫系统、上皮功能和肠道微生物群的影响有了很多了解;这些发现可能具有重大的实际意义。对接受肠内营养的患者进行的对照研究以及对采用排除饮食的患者的观察表明,全食物的成分可能对IBD患者产生有害影响。此外,动物模型研究表明,某些营养素可以减轻肠道炎症。未来,限制有害成分但补充有益营养素的特制饮食可用于改变IBD患者的肠腔环境;这些饮食可单独使用或与免疫抑制剂联合使用,或作为对药物治疗无反应或失去反应的患者的挽救疗法。可能需要更严格的饮食来诱导缓解,更可持续的排除饮食可用于维持长期缓解。